Gene · 1108
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ChAHP2 and ChAHP control diverse retrotransposons by complementary activities. | Genes Dev | 2024 | 38960717 | PubTator, text mining | PubMed |
| Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization. | J Headache Pain | 2024 | 38867170 | PubTator, text mining | PubMed |
| Spatiotemporal expression and control of haemoglobin in space. | Nat Commun | 2024 | 38862545 | PubTator, text mining | PubMed |
| iIMPACT: integrating image and molecular profiles for spatial transcriptomics analysis. | Genome Biol | 2024 | 38844966 | PubTator, text mining | PubMed |
| FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma. | Pathol Res Pract | 2024 | 38761648 | PubTator, text mining | PubMed |
| The immune cells have complex causal regulation effects on cancers. | Int Immunopharmacol | 2024 | 38710118 | PubTator, text mining | PubMed |
| Identification of key eRNAs for intervertebral disc degeneration by integrated multinomial bioinformatics analysis. | BMC Musculoskelet Disord | 2024 | 38704519 | PubTator, text mining | PubMed |
| lncRNA LINC00941 modulates MTA2/NuRD occupancy to suppress premature human epidermal differentiation. | Life Sci Alliance | 2024 | 38649186 | PubTator, text mining | PubMed |
| CHD4 and SMYD1 repress common transcriptional programs in the developing heart. | Development | 2024 | 38619323 | PubTator, text mining | PubMed |
| Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis - a cohort study of 70 adult patients with myositis in a single center. | Front Med (Lausanne) | 2024 | 38606156 | PubTator, text mining | PubMed |
| CHD4 acts as a prognostic factor and drives radioresistance in HPV negative HNSCC. | Sci Rep | 2024 | 38594331 | PubTator, text mining | PubMed |
| Clinicopathological Significance of Nucleosome Remodeling and Deacetylase Complex Expression in Endometrial Carcinoma. | Anticancer Res | 2024 | 38538000 | PubTator, text mining | PubMed |
| Gene amplification of chromatin remodeling factor SMARCC2 and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma. | Oncol Lett | 2024 | 38516682 | PubTator, text mining | PubMed |
| Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart. | J Anat | 2024 | 38419169 | PubTator, text mining | PubMed |
| Asymmetric darkened knuckles with subclinical myopathy revealed anti-Mi2b positive dermatomyositis. | Clin Rheumatol | 2024 | 38407713 | PubTator, text mining | PubMed |
| Identification and characterization of CHD4-associated eRNA as a novel modulator of fetal hemoglobin levels in β-thalassemia. | Biochem Biophys Res Commun | 2024 | 38325179 | PubTator, text mining | PubMed |
| CHD4-induced up-regulation of ERα activity contributes to breast cancer progression. | Genes Dis | 2024 | 38292202 | PubTator, text mining | PubMed |
| Genomic transcription factor binding site selection is edited by the chromatin remodeling factor CHD4. | Nucleic Acids Res | 2024 | 38281186 | PubTator, text mining | PubMed |
| Identification of a Novel Germline PPP4R3A Missense Mutation Asp409Asn on Familial Non-Medullary Thyroid Carcinoma. | Biomedicines | 2024 | 38275415 | PubTator, text mining | PubMed |
| Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition. | J Transl Med | 2024 | 38268032 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1108/papers?page=6